UNSPSC 51241142: Carmellose

It increases the tear viscosity, such as the product retention time also increases.

UNSPSC 51241142 Carmellose, a Commodity code, reflects state and local procurement of pharmaceutical raw materials and finished dosage forms, including carboxymethylcellulose sodium and related cellulose derivatives used as pharmaceutical binders, thickeners, and stabilizers. The recent MMCAP solicitation demonstrates that state and local bodies procure carmellose as part of broader generic pharmaceutical and OTC product portfolios distributed through multistate cooperative purchasing arrangements, with vendors supplying manufacturers' products meeting cGMP and FDA compliance standards for use across state and local health systems, correctional facilities, and social service agencies.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement on behalf of participating states including Oregon, issued an RFP (S1070000015802, due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products. Vendors must supply products through three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC—with all products available by May 15, 2026, and resulting agreements effective July 1, 2026. Evaluation weighs price competitiveness (75 percent), fixed pricing (10 percent), compliance with data format and EDI requirements (10 percent), and agreement to a 3 percent administrative fee (5 percent). Vendors must maintain contractual relationships with at least two of the three wholesalers, certify cGMP and Drug Supply Chain Security Act compliance, carry commercial general liability of $5 million per occurrence, and accept performance penalties of $200 to $1,500 per violation. The contract term runs two years for new vendors, with optional extensions at MMCAP's discretion.